Phase II Study of Irinotecan and Cisplatin as First-Line Chemotherapy in Advanced or Recurrent Cervical Cancer

Publisher： Karger

E-ISSN： 1423-0232|58|1|31-37

ISSN： 0030-2414

Source： Oncology, Vol.58, Iss.1, 2000-01, pp. : 31-37

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Irinotecan (CPT-11) and Cisplatin as First-Line Chemotherapy for Advanced Ovarian Cancer

By  

Oncology, Vol. 63, Iss. 1, 2002-08 ,pp. : 16-22

Karger

Access to resources Recommend Favorite

Phase I Study of Combination Chemotherapy Using Irinotecan Hydrochloride and Nedaplatin for Advanced or Recurrent Cervical Cancer

By  

Oncology, Vol. 65, Iss. 2, 2003-08 ,pp. : 102-107

Karger

Access to resources Recommend Favorite

First-Line Chemotherapy with Irinotecan plus Capecitabine for Advanced Colorectal Cancer

By  

Oncology, Vol. 66, Iss. 5, 2004-09 ,pp. : 353-357

Karger

Access to resources Recommend Favorite

A Phase II Trial of Irinotecan, 5-Fluorouracil and Leucovorin Combined with Celecoxib and Glutamine as First-Line Therapy for Advanced Colorectal Cancer

By  

Oncology, Vol. 69, Iss. 1, 2005-09 ,pp. : 63-70

Karger

Access to resources Recommend Favorite

Phase II Study of First-Line Sequential Chemotherapy with Gemcitabine-Carboplatin Followed by Docetaxel in Patients with Advanced Non-Small Cell Lung Cancer

By  

Oncology, Vol. 68, Iss. 4-6, 2005-08 ,pp. : 382-390

Karger

Access to resources Recommend Favorite